help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Van Vugt, D. A.
Right arrow Articles by Rivest, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Van Vugt, D. A.
Right arrow Articles by Rivest, S.
Endocrinology Vol. 138, No. 6 2249-2258
Copyright © 1997 by The Endocrine Society


ARTICLES

Luteinizing Hormone Secretion and Corticotropin-Releasing Factor Gene Expression in the Paraventricular Nucleus of Rhesus Monkeys Following Cortisol Synthesis Inhibition1

Dean A. Van Vugt, Jonathan Piercy, Anne E. Farley, Robert L. Reid and Serge Rivest

Department of Obstetrics and Gynecology (D.A.V.V., J.P., A.E.F., R.L.R.); Department of Physiology (D.A.V.V.), Queen’s University, Kingston, Ontario; and Laboratory of Molecular Endocrinology (S.R.), CHUL Research Center and Laval University, Quebec, Canada

Address all correspondence and requests for reprints to: Dean A. Van Vugt, Department of Obstetrics and Gynecology, 3022 Etherington Hall, Queen’s University, Kingston, Ontario, Canada, K7L 3N6.

Corticotropin-releasing Factor (CRF) is an important inhibitory neuromodulator of GnRH/LH secretion, and mediates in part the inhibitory effects of stress on the hypothalamic-pituitary-gonadal axis. The purpose of the present study was to further investigate CRF’s role in regulating LH secretion in primates. This was accomplished by examining LH secretion in ovariectomized rhesus monkeys (n = 7) following cortisol synthesis inhibition with metyrapone. Infusion of metyrapone (5 mg/kg per h) for 4 h decreased cortisol levels to less than 20% of controls while increasing ACTH approximately 10-fold. LH concentrations were not affected by this acute activation of the hypothalamic-corticotroph axis. In a second experiment, metyrapone was infused for 10 h before collecting serial blood samples every 15 min for 6 h. Although this protocol produced a sustained increase in ACTH, no apparent effect on pulsatile LH secretion compared with saline controls was observed. Mean LH SEM) levels calculated for consecutive 2-h increments were 87.6 ± 9.2 (0–2 h) 82.1 ± 5.5 (2–4 h), and 80.7 ± 4.8 (4–6 h) ng/ml in saline pretreated animals compared with 83.6 ± 4.9, 79.8 ± 5.8, and 72.5 ± 6.2 ng/ml, respectively, in metyrapone pretreated monkeys. The same regimen of metyrapone infusion increased CRF messenger RNA levels in the paraventricular nucleus by approximately 33% (P < 0.0002). In a final experiment designed to examine the potential synergy between CRF and cortisol, the LH response to insulin-induced hypoglycemia was contrasted in saline and metyrapone pretreated monkeys. LH concentrations were reduced to approximately 40% of basal levels following insulin in both metyrapone and saline pretreated monkeys. Therefore, even though inhibition of cortisol synthesis leads to an increase in CRF messenger RNA in the paraventricular nucleus and a robust increase in ACTH secretion in rhesus monkeys, presumably due in part to increased neuroendocrine CRF secretion, LH secretion was not inhibited during either the acute or more chronic phase of corticotroph activation. Absence of LH inhibition was not due to low cortisol concentrations resulting from metyrapone because metyrapone did not prevent hypoglycemia-induced suppression of LH secretion. We conclude that increased neuroendocrine CRF secretion following metyrapone does not inhibit LH secretion under these conditions. Several explanations for this result are discussed.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
B. Dudas and I. Merchenthaler
Close Juxtapositions between Luteinizing Hormone-Releasing Hormone-Immunoreactive Neurons and Corticotropin-Releasing Factor-Immunoreactive Axons in the Human Diencephalon
J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5778 - 5784.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. M. Oltmanns, B. Fruehwald-Schultes, W. Kern, J. Born, H. L. Fehm, and A. Peters
Hypoglycemia, But Not Insulin, Acutely Decreases LH and T Secretion in Men
J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4913 - 4919.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
S. Shridhar, A. Farley, R. L. Reid, W. G. Foster, and D. A. Van Vugt
The Effect of 2,3,7,8-Tetrachlorodibenzo-p-dioxin on Corticotrophin-Releasing Hormone, Arginine Vasopressin, and Pro-opiomelanocortin mRNA Levels in the Hypothalamus of the Cynomolgus Monkey
Toxicol. Sci., October 1, 2001; 63(2): 181 - 188.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Ferin
Stress and the Reproductive Cycle
J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 1768 - 1774.
[Full Text]


Home page
EndocrinologyHome page
K.-H. Jeong, L. Jacobson, E. P. Widmaier, and J. A. Majzoub
Normal Suppression of the Reproductive Axis Following Stress in Corticotropin-Releasing Hormone-Deficient Mice
Endocrinology, April 1, 1999; 140(4): 1702 - 1708.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1997 by The Endocrine Society